Skip to main content
Department of Internal Medicine

Department of Internal Medicine

Division of Hematology and Oncology News & Job Opportunities


January 2015

Study Listed as Major Achievement in Cancer Research & Care

Research led by Dr. Moon S. Chen working at the UC Davis Comprehensive Cancer Center was selected by the American Society of Clinical Oncology for inclusion in Clinical Cancer Advances 2015, the Society’s annual review of progress against cancer and emerging trends in the field. The study is titled, “Twenty years post-NIH Revitalization Act: Enhancing Minority Participation in Clinical Trials (EMPaCT): Laying the groundwork for improving minority clinical trial accrual.” Dr. Chen is extremely active on a regional, state and national level making a significant difference in obtaining effective treatment for cancer, along with his co-authors, Dr. Primo Lara, Dr. Julie Dang, Dr. Debora Paterniti, and Dr. Karen Kelly. Dr. Chen is especially known for making an impact in obtaining greater access to cancer care for minority populations. This study is featured as one of the year’s major achievements in clinical cancer research and care. To learn more, read the report at

December 2014

Abstract given Best of ASH status. First author Maricel Miguelino worked on this project under the mentorship of Dr. Jerry Powell of Internal Medicine, Hematology & Oncology and in collaboration with UC Davis Department of Surgery, Drs. Diana Farmer and Dr. Aijun Wang . Paper is entitled: In Utero Chorionic Villus Stem Cell Transplantation for the Treatment of Hemophilia A. Out of 6500 abstracts, Miguelino's abstract was recognized as one of the best 20 projects, and was the first one presented at The American Society of Hematology (ASH) conference at the 56th ASH Annual Meeting on December 7, 2014 which was attended by 26,000 delegates from around the world.

July 2014

 Sickle cell drug passes early phase trial

June 2014

Groundbreaking lung cancer trial launched 

October 2013

Dr. David Gandara

Dr. David Gandara, has recently been selected for the International Association for the Study of Lung Cancer Scientific Award which is given to an IASLC scientist for lifetime scientific contributions in thoracic malignancy research. The award will be presented at the World Conference on Lung Cancer at the end of October in Sydney, Australia. The IASLC is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 3,800 lung cancer specialists in 80 countries.  Past recipients of the award have been from the U.S., Canada, Belgium, France and Japan.

IASLC members work internationally to enhance the understanding of lung cancer among scientists, members of the medical community and the public. IASLC publishes the Journal of Thoracic Oncology, a valuable resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer.

May 2013

 Dr. Lara and Mathew Lara

Father and son to present their respective cancer research at ASCO

May 2013

Dr. Chong Pan has been honored with the Faculty Research Award for 2013. Dr. Pan will be recongnized at the 2013 Academic Forum and Award Presentation on May 16, 2013 at the PSSB Courtyard and Auditorium,11:00 AM to 1:30 PM.

Dr. Soames Boyle has been selected to receive an Internal Medicine Trainee Research Award.  Her paper "Splenectomy and the Incidence of Venous Thromboembolism and Sepsis in Patients with Immune Thrombocytopenia" was highly ranked.  She will be accepting the award at the 2013 Academic Forum and Award Presentation on May 16, 2013 at the PSSB Courtyard and Auditorium,11:00 AM to 1:30 PM.

April 2013

Dr. Karen Kelly the first to hold the Jennifer Rene Harmon Tegley and Elizabeth Erica Harmon Endowed Chair in Cancer Clinical Research


Seeking Two Full - Time Hospitalists

Seeking Full - Time Associate Physician

Seeking - Jr. Faculty Clinical X Series

Seeking Jr. Faculty HSCP Series

Seeking - Adult Hematologist-Hemophilia Director

Seeking - Jr. Faculty Clinical X Series